What is not recommended as treatment for mild preeclampsia?

In the context of mild preeclampsia, the recommendation is often to manage the condition with careful monitoring rather than pharmacological intervention. This includes strategies such as bed rest, monitoring of weight and blood pressure, and frequent assessments of urinary protein, serum creatinine, and platelet count to ensure the health of both the mother and the fetus.

While methyldopa is an antihypertensive medication that may be used in various hypertensive disorders during pregnancy, its use is more common in cases of gestational hypertension rather than mild preeclampsia. For mild preeclampsia, the focus typically lies on non-pharmacological management unless the blood pressure reaches levels that require treatment. Additionally, the primary goal is to observe and allow for spontaneous resolution as the pregnancy progresses, particularly if the condition is mild. Thus, the prescription of methyldopa is generally not recommended until a more severe form of preeclampsia, such as moderate to severe preeclampsia, necessitates such intervention.